167,105 Shares in Danaher Corporation $DHR Acquired by Cibc World Market Inc.

Cibc World Market Inc. bought a new stake in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, HoldingsChannel reports. The firm bought 167,105 shares of the conglomerate’s stock, valued at approximately $31,830,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Sivia Capital Partners LLC raised its position in Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after buying an additional 119 shares during the last quarter. First Trust Advisors LP lifted its stake in Danaher by 34.5% during the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after acquiring an additional 14,217 shares during the period. Main Street Financial Solutions LLC boosted its holdings in shares of Danaher by 40.2% during the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after acquiring an additional 886 shares during the last quarter. Ieq Capital LLC boosted its holdings in shares of Danaher by 64.2% during the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after acquiring an additional 29,592 shares during the last quarter. Finally, HUB Investment Partners LLC grew its stake in shares of Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock worth $273,000 after acquiring an additional 325 shares during the period. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.3%

DHR opened at $219.42 on Monday. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a market capitalization of $154.25 billion, a PE ratio of 38.97, a PEG ratio of 2.72 and a beta of 0.78. The firm’s 50 day simple moving average is $195.80 and its two-hundred day simple moving average is $192.40.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter in the previous year, the firm posted $0.77 EPS. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. As a group, equities analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Ratings Changes

DHR has been the subject of a number of research reports. Wells Fargo & Company decreased their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd. Guggenheim dropped their price target on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. HSBC lowered their target price on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Finally, Citigroup assumed coverage on Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.